Acadia Pharmaceuticals ACAD Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Acadia Pharmaceuticals's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Acadia Pharmaceuticals's total costs & expenses?
- Acadia Pharmaceuticals (ACAD) reported total costs & expenses of $272.68M in Q1 2026.
- How has Acadia Pharmaceuticals's total costs & expenses changed year-over-year?
- Acadia Pharmaceuticals's total costs & expenses increased by 21.2% year-over-year, from $225.03M to $272.68M.
- What is the long-term trend for Acadia Pharmaceuticals's total costs & expenses?
- Over 4 years (2021 to 2025), Acadia Pharmaceuticals's total costs & expenses has grown at a 10.2% compound annual growth rate (CAGR), from $654.58M to $966.69M.
- What does total costs & expenses mean?
- This metric represents the aggregate of all operating and non-operating costs incurred by the company to support its business activities during a specific period. It encompasses the sum of cost of goods sold, research and development investments, and selling, general, and administrative expenses. Monitoring this figure allows investors to evaluate the company's overall cost structure and operational efficiency relative to its revenue generation.